GOLDEN PROSPECT PRECIOUS METALS LIMITED

Director's Dealing • Dec 13, 2024

National Storage Mechanism | Additional information

RNS Number : 0755Q

Golden Prospect Precious Metals Ltd

13 December 2024

13 December 2024

Golden Prospect Precious Metals Limited (the "Company")

Director/PDMR shareholding

The Company wishes to announce in accordance with DTR 3.1 and Article 19 of the UK Market Abuse Regulation the following dealing in the Company's ordinary shares of no par value by persons discharging managerial responsibility:

Details of the person discharging managerial responsibilities/person closely associated

Name

Craig Cleland

Reason for the notification

Position/status

Head of Corporate Development - Manulife | CQS Investment Management

Initial Notification Amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Golden Prospect Precious Metals Limited

LEI

549300SD5YLRIUMG395

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial  instrument,

type  of

instrument

Identification code

Ordinary shares

ISIN: GG00B1G9T992

Nature of the transaction  

Subscription Rights Issue

Price(s) and volume(s)

Price(s)	Volume(s)
GBP 0.3594	18,000

Aggregated information

- Aggregated volume

- Price

18,000

£6,469.20

Date of the transaction

11 December 2024

Place of the transaction

LONDON STOCK EXCHANGE, (XLON)

Additional Information

This announcement is made in accordance with the requirements of the UK Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.

Enquiries:

Apex Administration (Guernsey) Limited

James Taylor                                                                +44 (0) 2035 303 600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBDBDDSBBDGSX